Publicaciones en las que colabora con ANA MARIA GONZALEZ PINTO ARRILLAGA (16)

2024

  1. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2021

  1. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms

    Frontiers in Psychiatry, Vol. 12

  2. Gender-Based Analysis of the Psychological Impact of the COVID-19 Pandemic on Healthcare Workers in Spain

    Frontiers in Psychiatry, Vol. 12

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  3. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

  4. Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment

    Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267

2017

  1. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

    Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577

  2. Relationship between the use of benzodiazepines and falls in older adults: A systematic review

    Maturitas, Vol. 101, pp. 17-22

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2008

  1. Curso del funcionamiento cognitivo en primeros episodios psicóticos: estudio comparativo entre esquizofrenia y otros diagnósticos psicóticos

    Revista de Psiquiatria y Salud Mental, Vol. 1, Núm. 1, pp. 18-25

2001

  1. La actividad enzimática MAO-B no es un marcador válido para discriminar entre subtipos de alcoholismo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 3, Núm. 4, pp. 292-293